Wondfo Biotech convertible bonds see minimal conversion in Q3 2025

Guangzhou Wondfo Biotech announced that for the third quarter of 2025 (July 1 to September 30), only 10 "Wondfo Convertible Bonds," totaling CNY 1,000, were converted into 37 shares. As of September 30, 2025, 5,976,880 convertible bonds remain outstanding, representing an unconverted ratio of 99.61%.

The initial conversion price for "Wondfo Convertible Bonds," which began conversion on March 8, 2021, was RMB 93.55 per share. Following several adjustments, the conversion price was last adjusted to RMB 27.00 per share on December 26, 2024. Most recently, following a 2024 profit distribution plan, the conversion price was adjusted to RMB 26.60 per share, effective May 20, 2025.

The company's total share capital as of September 30, 2025, stands at 468,084,798 shares.